Saturday, March 3, 2012

FDA mandates new safety warnings for statin drugs due to risks of memory loss, diabetes and muscle pain

(NaturalNews) On February 28, federal health officials added new safety alerts to the prescribing information for statin drugs, citing increased risks of memory loss, diabetes and muscle pain. It is the first time the United States Food and Drug Administration (FDA) has officially linked statins to cognitive problems like forgetfulness and confusion, though such problems have been reported for several years.

For the rest of the article click Here.

No comments:

Post a Comment